AlphaMark Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-100
| Closed | -$4K | – | 632 |
|
|
2022
Q4 | $4K | Buy |
100
+28
| +39% | +$1.12K | ﹤0.01% | 466 |
|
|
2022
Q3 | $2K | Hold |
72
| – | – | ﹤0.01% | 594 |
|
|
2022
Q2 | $4K | Hold |
72
| – | – | ﹤0.01% | 488 |
|
|
2022
Q1 | $4K | Hold |
72
| – | – | ﹤0.01% | 497 |
|
|
2021
Q4 | $4K | Hold |
72
| – | – | ﹤0.01% | 473 |
|
|
2021
Q3 | $3K | Sell |
72
-8
| -10% | -$333 | ﹤0.01% | 510 |
|
|
2021
Q2 | $4K | Hold |
80
| – | – | ﹤0.01% | 475 |
|
|
2021
Q1 | $4K | Hold |
80
| – | – | ﹤0.01% | 459 |
|
|
2020
Q4 | $4K | Hold |
80
| – | – | ﹤0.01% | 433 |
|
|
2020
Q3 | $4K | Hold |
80
| – | – | ﹤0.01% | 448 |
|
|
2020
Q2 | $4K | Buy |
80
+56
| +233% | +$2.8K | ﹤0.01% | 447 |
|
|
2020
Q1 | $1K | Buy |
+24
| New | +$1K | ﹤0.01% | 516 |
|